Previous 10 | Next 10 |
Verastem, Inc. (Nasdaq:VSTM) (Verastem Oncology or the Company), focused on developing and commercializing medicines seeking to improve the survival and quality of life of cancer patients, today announced that the Company will present at the Jefferies 2019 Global Healthcare Conference on Fri...
"It's far better to buy a wonderful company at a fair price than a fair company at a wonderful price." - Warren Buffett I enjoy conducting investment research because of the intellectual challenges that each unique company presents. And, I feed off the excitement associated with putting to...
Verastem, Inc. (Nasdaq:VSTM) (Verastem Oncology or the Company), focused on developing and commercializing medicines seeking to improve the survival and quality of life of cancer patients, today announced that the Company will present at the 20 th Annual B. Riley FBR Institutional Investor ...
Abstract Highlights the Effect of Dose Modification on Response to COPIKTRA in Adult Patients with CLL/SLL After At Least Two Prior Therapies Dose Interruptions of a Median 15 days Do Not Significantly Impact Response or PFS Data Demonstrate That Dose Modifications Can be Used to ...
Gainers: Big 5 Sporting Goods (NASDAQ: BGFV ) +26% . Novavax (NASDAQ: NVAX ) +25% . Asta Funding (NASDAQ: ASFI ) +20% . MeiraGTx Holdings (NASDAQ: MGTX ) +19% . Luokung Technology (NASDAQ: LKCO ) +18% . Key Energy Services (NYSE: KEG ) +17% . Verastem (NASDAQ: VSTM ) +17% . Su...
Gainers: Charles & Colvard (NASDAQ: CTHR ) +34% . Buckeye Partners (NYSE: BPL ) +28% . Cardlytics (NASDAQ: CDLX ) +26% . G1 Therapeutics (NASDAQ: GTHX ) +24% . Westport Fuel Systems (NASDAQ: WPRT ) +21% . Cool Holdings (NASDAQ: AWSM ) +22% . Guardant Health (NASDAQ: GH ) +...
Puma Biotechnology (NASDAQ: PBYI ) -35% on Q1 earnings . More news on: Puma Biotechnology, Inc., TransEnterix, Inc., Verastem, Inc., Stocks on the move, Read more ...
Verastem, Inc. (VSTM) Q1 2019 Earnings Conference Call May 09, 2019, 16:30 ET Company Participants John Doyle - VP, IR Robert Forrester - President, CEO & Director Joseph Lobacki - EVP & Chief Commercial Officer Daniel Paterson - COO Robert Gagnon - CFO Conference ...
Alongside Q1 results, the company says it expects full-year Copiktra sales to be $10M-$12M, far short of estimates in the $40M area. More news on: Verastem, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, , Read more ...
Verastem (NASDAQ: VSTM ): Q1 GAAP EPS of -$0.52 misses by $0.05 . Revenue of $1.67M misses by $1.15M . Press Release More news on: Verastem, Inc., Earnings news and commentary, Healthcare stocks news, ,
News, Short Squeeze, Breakout and More Instantly...
A look at the top 10 most actives in the United States Sangamo Therapeutics Inc. (SGMO) rose 50.7% to $0.604699 on volume of 90,844,210 shares Selina Hospitality PLC (SLNA) rose 7.7% to $0.028 on volume of 57,431,570 shares NuZee Inc. (NUZE) rose 260.1% to $3.7094 on volume of 53,639,595 ...
Verastem Oncology, (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the pricing of an underwritten public offering of 13,333,334 shares of its common stock and accompanying warrants to purchase up to 13,333,334 shares of it...
Verastem Oncology, (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that it intends to offer and sell shares of its common stock and accompanying warrants to purchase shares of common stock, as well as pre-funded warrants t...